These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28389634)

  • 1. Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case.
    Kalogeropoulos D; Kitsos G; Konstantinidis A; Gartzonika C; Svarna E; Malamos K; Katsanevakis E; Kalogeropoulos C
    Am J Case Rep; 2017 Apr; 18():367-374. PubMed ID: 28389634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TATTOO-ASSOCIATED CASES OF POSTERIOR SEGMENT UVEITIS WITH VOGT-KOYANAGI-HARADA DISEASE-LIKE FEATURES.
    Kesav NP; Kaplan AJ; Hwang CK; Okeagu C; Sen HN
    Retin Cases Brief Rep; 2022 Jul; 16(4):457-460. PubMed ID: 32502130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Vogt-Koyanagi-Harada syndrome: a rare differential diagnosis of uveitis in childhood. A case report taking into account the revised diagnostic criteria].
    Rieger R; Keitzer R; Pleyer U
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):919-22. PubMed ID: 16308827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitiligo revealing Vogt -Koyanagi-Harada disease].
    Amraoui ME; Zemmez Y; Bouhamidi A; Frikh R; Hjira N; Boui M
    Pan Afr Med J; 2017; 27():220. PubMed ID: 28979622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TUBERCULOUS CHOROIDITIS IN PATIENT WITH VOGT-KOYANAGI-HARADA DISEASE.
    Anderson EW; El Khoury L; Schwartzman-Morris JS; Jonisch J; Goldberg NR
    Retin Cases Brief Rep; 2021 May; 15(3):302-305. PubMed ID: 30074567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chinese expert consensus on the clinical diagnosis and treatment of Vogt-Koyanagi-Harada syndrome (2023)].
    ;
    Zhonghua Yan Ke Za Zhi; 2023 Jul; 59(7):518-525. PubMed ID: 37408422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease.
    Rao NA; Gupta A; Dustin L; Chee SP; Okada AA; Khairallah M; Bodaghi B; Lehoang P; Accorinti M; Mochizuki M; Prabriputaloong T; Read RW
    Ophthalmology; 2010 Mar; 117(3):591-9, 599.e1. PubMed ID: 20036008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
    Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vogt-Koyanagi-Harada disease in a patient of chronic myeloid leukemia.
    Chawla R; Meena S; Tomar AS; Venkatesh P; Vohra R
    Indian J Ophthalmol; 2017 May; 65(5):411-413. PubMed ID: 28574001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral conjunctival nodules: an unusual manifestation of Vogt-Koyanagi-Harada syndrome.
    Yang MC; Huang AJ
    Arch Ophthalmol; 2004 Dec; 122(12):1878-81. PubMed ID: 15596596
    [No Abstract]   [Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada syndrome and pregnancy.
    Steahly LP
    Ann Ophthalmol; 1990 Feb; 22(2):59-62. PubMed ID: 2316953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.